Hongxin Li, Wenbin Guo, Lijun Sheng, Zhengjun Wang, Hao Liang, Chengwei Zou, Liang Du, Guidao Yuan
Department of Cardiovascular Surgery, Shandong Provincial Hospital, Shandong University, Jinan, China.
J Thorac Cardiovasc Surg. 2007 Oct;134(4):946-51. doi: 10.1016/j.jtcvs.2007.05.002.
This study aims to report our experience using intraoperative device closure of secundum atrial septal defects and to evaluate the feasibility and clinical outcome of this technique.
One hundred patients with secundum atrial septal defects (mean age, 29 +/- 16 years; age range, 5-71 years; mean weight, 54 +/- 18 kg; weight range, 16-94 kg) underwent intraoperative device closure through a right minithoracotomy without cardiopulmonary bypass and fluoroscopy. A 2.5- to 3-cm parasternal or submammary incision was made in the right third or fourth intercostal space. Exposed with a miniretractor, a specially designed plastic sheath loaded with the device was inserted through the purse-string sutures placed on the right atrium. Under transesophageal echocardiographic guidance, it was advanced through the atrial septal defect into the left atrium, and the device was deployed in place.
The procedure was successful in all patients, including 5 patients with double atrial septal defects. The maximum diameter of the atrial septal defect ranged from 5 to 37 mm (mean, 21 +/- 7 mm). There were 61 patients with an atrial septal defect diameter of more than 20 mm, 16 of them with a diameter of more than 30 mm. The mean size of implanted devices was 25 +/- 7 mm (range, 8-36 mm). Residual shunts were found in 9 (9%) patients immediately after the operation. The complete occlusion rate was 95% at discharge, 99% at the 3-month follow-up, and 100% at the 1-year follow-up. There were no other late complications during the follow-up period.
Intraoperative device closure is a safe, cost-effective, cosmetic, and less-invasive operation of most secundum atrial septal defects. Follow-up results are encouraging. It can be considered an acceptable alternative to transcatheter closure or surgical repair.
本研究旨在报告我们使用术中装置闭合继发孔型房间隔缺损的经验,并评估该技术的可行性和临床结果。
100例继发孔型房间隔缺损患者(平均年龄29±16岁;年龄范围5 - 71岁;平均体重54±18 kg;体重范围16 - 94 kg)通过右胸小切口在非体外循环和无透视下进行术中装置闭合。在右第三或第四肋间做一个2.5至3厘米的胸骨旁或乳房下切口。用微型牵开器暴露后,将装有装置的特制塑料鞘通过置于右心房的荷包缝线插入。在经食管超声心动图引导下,将其穿过房间隔缺损推进到左心房,并将装置展开到位。
该手术在所有患者中均成功,包括5例双房间隔缺损患者。房间隔缺损的最大直径为5至37毫米(平均21±7毫米)。有61例房间隔缺损直径大于20毫米,其中16例直径大于30毫米。植入装置的平均尺寸为25±7毫米(范围8 - 36毫米)。术后立即发现9例(9%)患者有残余分流。出院时完全闭塞率为95%,3个月随访时为99%,1年随访时为100%。随访期间无其他晚期并发症。
术中装置闭合是大多数继发孔型房间隔缺损安全、经济、美观且侵入性较小的手术。随访结果令人鼓舞。它可被视为经导管闭合或手术修复的可接受替代方法。